Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Chris says Insider ownership is ~13%.
These numbers seem out of whack to me. I emailed Chris with a link to that site to see if he agrees with those numbers. I'll let you know what he says.
For one, I don't think Allan Spissinger owns 769k shares. In Jan my site showed 3,972 shares for him. Also, Brian Quigley only owned 3,333 as of the Reverse Split. Also it shows the new director Bhullar owns more than twice the shares owned by John Docherty?? huh??
Maybe my numbers are wrong :)
On Jan 13, 2021, Insider ownership was 575,943 shares. They haven't changed it that much since then.
I support progress no matter how we get it. Also, careful what you wish for...a new CEO may be worse, believe it or not.
You might just get your wish as Chris has mentioned in two interviews that I know of that he is nearing the end of his career.
Officially ignored #2
Officially Ignored
Bunka's interview on CBD beverage test results
Positive New CBD Beverage testing results
https://ir.lexariabioscience.com/news-events/press-releases/detail/123/lexaria-technology-generates-positive-stability-testing-for
It's his opinion about Bunka needing to step down that he keeps repeating pretty much everyday.
He also twists the truth about Bunka not coming through on promises when although some deals haven't worked out doesn't mean Bunka didn't come through on promises. Bunka says what he's working towards deals but never promises things will happen. I challenge anyone to find an article or news release where Bunka promised anything. No CEO in their right mind would make such a promise. Now I'm sure everyone will try to argue that he does this all the time but they won't post a link because they're just making these stories up to discredit Lexaria.
Also, funny how there are endless positive news releases and deals that were made by Lexaria that are not mentioned by Harlem or the naysayers.
I'm long, I am down on paper but I'm not whining daily about what a crappy job Bunka is doing. I think he's done a great job and the prospects for a prosperous future are heating way up. IMO, it's just a matter of time before all the naysayers will be eating crow big time.
At any rate, anyone who thinks the random BS sessions on message boards are reality needs to do some real due diligence on the company.
Have you ever really listened to yourself?
You'd like that I'm sure.
If you were to actually have read it you would see that it's a recap of things that have happened and he is very careful not to make promises.
New Ohashi/ Bunka interview. Interesting read.
Starts on pg. 9
https://4495825a-d729-4d8f-ade8-e78f828e1c8d.usrfiles.com/ugd/449582_0d477cbfb455410cb97108acc47cfece.pdf
BAT hasn't made a decision re: the nicotine study yet. If they had made a decision either way, there would be a news release. There is no NR.
He bought the shares before Nov 10, 2020.
Item 5. Interest in Securities of the Issuer
Item 5 to Schedule 13D is amended and restated as follows:
(a)The Reporting Persons acquired the Shares in a number of transactions between September 18, 2015 and November 10, 2020. In addition, the Issuer completed a reverse stock split on a one for 30 basis on January 11, 2021.
https://ir.lexariabioscience.com/sec-filings/all-sec-filings##document-1608-0001640334-21-000425-2
Seems like this form from today was just an amendment due to some details like the RS.
If you don't think the company is doing anything worthwhile like I do then don't buy it or sell your shares or short the stock or whatever. Have you all forgotten that the company actually does work that could eventually benefit the whole world with its technology even saving many lives. I've never seen such a bunch of negatively minded individuals in my life anywhere. Maybe trying to support the company might be more productive for the world. I'm done with you all.
I'm not going to debate whether what Chris told me is true or not. If you don't understand the situation with Lexaria, I suggest giving Chris a call and having a talk with him.
Bunka and the others just took a 40% hit along with the rest of us.
2 raises in eight months at 4M is not one raise for 11M. Big difference.
Also, I don't think Chris ever thought Altria would bankroll Lexaria.
According to Chris, Lexaria uplisted and did this raise because it was impossible for them to accomplish such a large raise while on the OTC. Of course they were charged heavily for it but it has given them a huge amount of money to do the valuable work they need to do to remain a going concern.
This is the price businesses sometimes have to pay for getting ahead. It's very common.
I understand how it works but so far even Chris doesn't know who the investors were that HCW rounded up. I asked him about that yesterday in an email.
Did you not notice HC Wainwright investment bank infusing $11M. That's what Bunka was talking about. He was only able to raise a couple of million at a time on the OTC.
No one is just going to give us money without getting something in return.
I'm not worried in the slightest. I was responding to a baseless comment from someone else.
Bunka was at $75 US ($2.25 pre-split) and he didn't sell then. Why would he sell at $30 ($1 pre-split) now?
Cmon, you love it!
I guess you're right about the salary, I just saw the $75,000.
Regardless of all the shenanigans that go on with CEO's of companies though, I bought this company because I think they're going places and so you're basically talking to the hand as far as trying to convince me otherwise. I'll be holding my shares till they're worth a good price or no price at all, all or nothing.
I'm going by the just released actual figures as opposed to the planned figures, see pg. 4 of 31
https://ir.lexariabioscience.com/sec-filings/quarterly-reports/content/0001640334-21-000104/0001640334-21-000104.pdf
Agreed. Imagine the uproar if we got rejected by Nasdaq at the last minute. People would be complaining for years.
Revenue 28x higher than same period last year!!!
If your guess is revenue is 4 times higher than salaries, you are correct.
I see $192,261 for R&D and 75,498 for wages and salaries.
https://ir.lexariabioscience.com/sec-filings/quarterly-reports/content/0001640334-21-000104/0001640334-21-000104.pdf
Holy Gloom and Doom Batman
If it was up to you for sure the company would fail.
Money from Altria wouldn't have helped them pay for all the new studies they have planned and to pay for patents etc. Last time Altria gave us a million bucks was to work with Altria. It wasn't just play money.
I agree with the "if he had something scenario" but we can't write off what happens on any given day from now onward because of what didn't happen. Deals that get made will always be a surprise.
What we need is a "Halt" with a big announcement of a new partnership and series of studies to follow. Perhaps in relation to positive CBD Hypertension study results or a surprise BAT or Altria announcement :)
Last year's Q4 came out on Jan 9th so likely any day.
If Bunka could have raised that kind of money on the OTC why would he want to uplist? It only makes sense that he couldn't have raised the large amount on the OTC and had to uplist.